Position in ANAB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,807,066
+$972,232 QoQ
Shares Held
56,401
-26.4% QoQ
Ownership
0.194%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 211 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. ANAB ranks #113 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ANAB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,807,066 | 56,401 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $2,834,834 | 51,115 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $2,683,123 | 55,345 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $1,746,254 | 57,030 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $1,314,793 | 59,225 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $1,137,833 | 61,207 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $756,919 | 57,169 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $1,981,219 | 59,141 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,867,224 | 74,510 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $1,443,235 | 64,087 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $1,500,170 | 70,036 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $1,246,508 | 69,405 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $1,411,209 | 69,381 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $1,653,849 | 76,004 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $2,387,685 | 77,047 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,145,496 | 84,104 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,568,007 | 77,242 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,095,843 | 84,715 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,973,908 | 85,580 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $2,224,815 | 82,036 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $2,044,609 | 78,851 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $2,164,248 | 100,429 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,151,843 | 100,086 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,559,510 | 105,730 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $2,419,995 | 108,326 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,478,914 | 104,665 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||